Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool

Bibliography

• Edwards BK, Ward E, Kohler BA, Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates (p 544-573). Cancer 2010;116:544-73
   PubMed Web of Science ®Google Scholar
• Ponomarev V. Nuclear imaging of cancer cell therapies. J Nucl Med 2009;50:1013-16
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Tortora G. Review. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001;7:2958-70
   PubMed Web of Science ®Google Scholar
• Ehrlich P. Collected studies on immunity. John Wiley and Sons, New York; 1906
   Google Scholar
• Bangham AD. Lipid bilayers and biomembrane. Annu Rev Biochem 1972;41:753-76
   PubMed Web of Science ®Google Scholar
• Lu Y, Madu CO. Viral-based gene delivery and regulated gene expression for targeted cancer therapy. Expert Opin Drug Deliv 2010;7:19-35
   PubMed Web of Science ®Google Scholar
• Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 2003;3:477-88
   PubMed Web of Science ®Google Scholar
• Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Tabata Y. Non-viral vectors for cancer therapy. Cancer Sci 2006;97:348-54
   PubMed Web of Science ®Google Scholar
• Morille M, Passirani C, Vonalbourg A, Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008;29:3477-96
   PubMed Web of Science ®Google Scholar
• Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 2009;11:671-81
   PubMed Web of Science ®Google Scholar
• Felgner PL, Gadek TR, Holm M, Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-17
   PubMed Web of Science ®Google Scholar
• Wheeler CJ, Felgner PL, Tsai YJ, A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 1996;93:11454-9
   PubMed Web of Science ®Google Scholar
• Nabel GJ, Nabel EG, Yang Z-Y, Direct gene transfer with DNA-liposome complexes in melanoma; expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993;90:11307-11
   PubMed Web of Science ®Google Scholar
• Bergen M, Chen, R, Gonzalez R. Efficacy and safety of HLA-B7/ beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma. Expert Opin Biol Ther 2003;3:377-84
   PubMed Web of Science ®Google Scholar
• Yoshida J, Mizuno M, Fujii M, Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum Gene Ther 2004;15:77-86
   PubMed Web of Science ®Google Scholar
• Wattiaux R, Laurent N, Wattiaux-De Cornick S, Endosomes, lysosomes: their implication in gene transfer. Adv Drug Deliv Rev 2000;41:201-8
   PubMed Web of Science ®Google Scholar
• El Ouahabi A, Thiry M, Pector V, The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett 1997;414:187-92
   PubMed Web of Science ®Google Scholar
• Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta 1995;1235:289-95
   PubMed Web of Science ®Google Scholar
• Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008;99:392-7
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-84
   PubMed Web of Science ®Google Scholar
• Litzinger DC, Buiting AM, van Rooijen N, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1994;1190:99-107
   PubMed Web of Science ®Google Scholar
• Siehl JM, Thiel E, Schmittel A, Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study. Cancer 2005;104:611-17
   PubMed Web of Science ®Google Scholar
• Del Barco S, Colomer R, Calvo L, Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial. Breast Cancer Res Treat 2009;116:351-8
   PubMed Web of Science ®Google Scholar
• Thomas DA, Kantarjian HM, Stock W, Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study. Cancer 2009;115:3475-82
   PubMed Web of Science ®Google Scholar
• Kircheis R, Wagner E. Transferrin receptor-targeted gene delivery systems. In: Amiji MM, editor. Polymeric gene delivery. CRC Press LLC, Florida; 2005. p. 537-56
   Google Scholar
• Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41:147-62
   PubMed Web of Science ®Google Scholar
• Clement V, Dutoit V, Marino D, Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer 2009;125:244-8
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Therap 2006;112:630-48
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Hamaguchi T, Ura T, Phase I clinical trial and pharmacokinetic evaluation of NK911, micelle-encapsulated doxorubicin. Br J Cancer 2004;91:1775-81
   PubMed Web of Science ®Google Scholar
• Han M, Oba M, Nishiyama N, Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles. Mol Ther 2009;17:1404-10
   PubMed Web of Science ®Google Scholar
• Bae Y, Nishimura N, Fukushima S, Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property; tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005;16:122-30
   PubMed Web of Science ®Google Scholar
• Kim D, Gao Z, Lee E, Bae Y. In vivo evaluation of doxorubicin-loaded polymeric mecelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm 2009;6:1353-62
   PubMed Web of Science ®Google Scholar
• Hanai K, Kurokawa T, Minakuchi Y, Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease. Hum Gene Ther 2004;15:263-72
   PubMed Web of Science ®Google Scholar
• Takeshita F, Minakuchi Y, Nagahara S, Efficient delivery off small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 2005;102:12177-82
   PubMed Web of Science ®Google Scholar
• Fukunaka Y, Iwanaga K, Morimoto K, Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release 2002;80:333-43
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 2004;11:1205-14
   PubMed Web of Science ®Google Scholar
• Erbacher P, Zou S, Bettinger T, Chitosan-based vector/DNA complexes for gene delivery; biophysical characteristics and transfectun ability. Pharm Res 1998;15:1332-9
   PubMed Web of Science ®Google Scholar
• Kim TH, Jin H, Kim HW, Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther 2006;5:1723-32
   PubMed Web of Science ®Google Scholar
• Howard KA, Rahbek UL, Liu X, RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 2006;14:476-84
   PubMed Web of Science ®Google Scholar
• Neu N, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 2005;7:992-1009
   PubMed Web of Science ®Google Scholar
• Boussif O, Lezoualch F, Zanta MA, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301
   PubMed Web of Science ®Google Scholar
• Alshamsan A, Hamdy S, Samuel J, The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Biomaterials 2010;31:1420-8
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8
   PubMed Web of Science ®Google Scholar
• Wolff JA, Budker V. The mechanism of naked DNA uptake and expression. Adv Genet 2005;54:3-20
   PubMed Web of Science ®Google Scholar
• Jiao S, Williams P, Berg RK, Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992;3:21-33
   PubMed Web of Science ®Google Scholar
• Available from: http://www. wiley.co.uk/genmed/clinical/ [Last accessed August 10, 2010]
   Google Scholar
• Wells D. Gene therapy progress and prospects; electroporation and other physical methods. Gene Ther 2004;11:1363-9
   PubMed Web of Science ®Google Scholar
• Liu F, Huang L. A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther 2002;3:323-8
   Google Scholar
• Zhu S, Lee DA, Li S. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 2010;184:2348-54
   PubMed Web of Science ®Google Scholar
• Vidic S, Markelc B, Sersa G, MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther 2010;17:409-19
   PubMed Web of Science ®Google Scholar
• Kyte JA, Mu L, Aamdal S, Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther 2006;13:905-18
   PubMed Web of Science ®Google Scholar
• Daud AI, DeConti RC, Andrews S, Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008;26:5896-903
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Tachibana K, Hiraoka K, Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-80
   PubMed Web of Science ®Google Scholar
• Kim HJ, Greenleaf JF, Kinnick RR, Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996;7:1339-46
   PubMed Web of Science ®Google Scholar
• Casey G, Cashman JP, Morrissey D, Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med Biol 2010;36:430-40
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Tominaga K, Yamamoto K, Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007;14:354-63
   PubMed Web of Science ®Google Scholar
• Hayashi S, Mizuno M, Yoshida J, Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther 2009;16:638-43
   PubMed Web of Science ®Google Scholar
• Suzuki R, Namai E, Oda Y, Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010;142:245-50
   PubMed Web of Science ®Google Scholar
• Hodges BL, Scheule RK. Hydrodynamic delivery of DNA. Expert Opin Biol Ther 2003;3:911-18
   PubMed Web of Science ®Google Scholar
• Zhang G, Budker V, Williams P, Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001;12:427-38
   PubMed Web of Science ®Google Scholar
• Romero NB, Benveniste O, Payan C, Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part II: clinical protocol. Neuromuscul Disord 2002;12(Suppl 1):S45-8
   PubMedGoogle Scholar
• Sawyer GJ, Rela M, Davenport M, Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application. Curr Gene Ther 2009;9:128-35
   PubMed Web of Science ®Google Scholar
• Yazawa H, Murakami T, Li HM, Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. Cancer Gene Ther 2006;13:993-1001
   PubMed Web of Science ®Google Scholar
• Neal ZC, Bates MK, Albertini MR, Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity. Mol Ther 2007;15:422-30
   PubMed Web of Science ®Google Scholar
• Mumper RJ, Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods 2003;31:255-62
   PubMed Web of Science ®Google Scholar
• Bins AD, Jorritsma A, Wolkers MC, A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005;11:899-904
   PubMed Web of Science ®Google Scholar
• Lund PE, Hunt RC, Gottesman MM, Pseudovirions as vehicles for the delivery of siRNA. Pharm Res 2010;27:400-20
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Saeki Y, Morishita R. Gene therapy using HVJ-liposomes; the best of both worlds. Mol Med Today 1999;5:298-303
   PubMedGoogle Scholar
• Okada Y. Sendai virus-induced cell fusion. In: Duzgunes N, editor. Methods in enzymology. Volume 221. Academic Press, Inc., San Diego; 1993. p. 18-41
   Google Scholar
• Nakamura N, Hart DA, Frank CB, Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition. J Biochem 2001;129:755-9
   PubMed Web of Science ®Google Scholar
• Wagner E, Plank C, Zatloukal K, Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 1992;89:7934-8
   PubMed Web of Science ®Google Scholar
• Zhou W-Z, Hoon DSB, Huang SKS, RNA melanoma vaccine; induction of anti-tumor immunity by human gp100 mRNA immunization. Hum Gene Ther 1999;10:2719-24
   PubMed Web of Science ®Google Scholar
• Kawashita Y, Ohtsuru A, Miki F, Eradication of hepatocellular carcinoma xenografts by radiolabelled lipiodol-inducible gene therapy. Gene Ther 2005;12:1633-9
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Nakajima T, Nishikawa T, HVJ (hemagglutinating virus of Japan) envelope vector as a versatile gene delivery system. Mol Ther 2002;6:219-26
   PubMed Web of Science ®Google Scholar
• Kaneda Y. Applications on hemagglutinating virus of Japan in therapeutic delivery system. Expert Opin Drug Deliv 2008;5:221-33
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Miyamoto Y, Inoue T, Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. Int J Cancer 2009;124:2478-87
   PubMed Web of Science ®Google Scholar
• de Jonge J, Holtrop M, Wilschut J, Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther 2006;13:400-11
   PubMed Web of Science ®Google Scholar
• Yamada T, Iwasaki Y, Tada H, Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nature Biotech 2003;21:885-90
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Ueda M, Yamada T, Gene therapy of liver tumors with human liver-specific nanoparticles. Cancer Gene Ther 2007;14:74-81
   PubMed Web of Science ®Google Scholar
• Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res 2003;9:5055-67
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Tanaka N, Kanazawa S, Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer. J Clin Oncol 2006;24:1689-99
   PubMed Web of Science ®Google Scholar
• O'Neill D, Bhardwaj N. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection. Methods Mol Med 2005;109:1-18
   PubMedGoogle Scholar
• Kim R, Emi M, Tanabe K. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive network for tumor immunity. Immunology 2006;119:254-64
   PubMed Web of Science ®Google Scholar
• Dudley ME, Yang JC, Sherry R, Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 2008;26:5233-9
   PubMed Web of Science ®Google Scholar
• Kirkwood JM, Tarhini AA, Panelli MC, Next generation of immunotherapy for melanoma. J Clin Oncol 2008;20:3445-55
   Google Scholar
• Samuel M, Chow PK, Chan S-Y, Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Database Syst Rev 2009;(1):CD001199
   Google Scholar
• Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Mol Ther 2007;15:651-9
   PubMed Web of Science ®Google Scholar
• Liu TC, Kirn D. Gene therapy progress and prospects cancer: oncolytic viruses. Gene Ther 2008;15:877-84
   PubMed Web of Science ®Google Scholar
• Kirn DH, Thorne SH. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer 2009;9:64-71
   PubMed Web of Science ®Google Scholar
• Semple SC, Harasym TO, Clow KA, Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J Pharmacol Exp Ther 2005;312:1020-6
   PubMed Web of Science ®Google Scholar
• Yew NS, Scheule RK. Toxicity of cationic lipid-DNA complexes. Adv Genet 2005;53:189-214
   PubMed Web of Science ®Google Scholar
• Huckriede A, Bungener L, Daemen T, Influenza virosomes in vaccine development. Methods Enzymol 2003;373:74-91
   PubMed Web of Science ®Google Scholar
• Adamina M, Schumacher R, Zajac P, Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy. J Liposome Res 2006;16:195-204
   PubMed Web of Science ®Google Scholar
• Felnerova D, Viret JF, Gluck R, Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 2004;15:518-29
   PubMed Web of Science ®Google Scholar
• Kurooka M, Kaneda Y. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res 2007;67:227-36
   PubMed Web of Science ®Google Scholar
• Fujihara A, Kurooka M, Miki T, Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunol Immunother 2008;57:73-84
   PubMed Web of Science ®Google Scholar
• Somia N, Verma IM. Gene therapy: trials and tribulations. Nat Rev Genet 2000;1:91-9
   PubMed Web of Science ®Google Scholar
• Kawano H, Komaba S, Kanamori T, A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy. BMC Med 2007;5:28
   PubMedGoogle Scholar